Pharmacy prescribing: 'Absence of reported harm not evidence of a safe system'
By Medical Forum
News & Features
Top Reads
GPs in WA can now diagnose and prescribe for ADHD
The first cohort of GPs to undergo specialist ADHD training in WA can now begin diagnosing and prescribing for the condition.
Doctor registration fees increase above Medicare indexation
Annual registration fees for doctors have increased by 4% - here’s what you’ll be paying.
Mental health the biggest unmet need for WA women
Mental health is the single biggest unmet need for Western Australian women when it comes to health services.
Pharmacy prescribing: 'Absence of reported harm not evidence of a safe system'
Even if pharmacists were to strictly adhere to protocols, their prescribing may unintentionally contribute to serious negative outcomes for patients, the RACGP has warned.
New stats show a third of all WA GP clinics are fully bulk billing
The number of fully bulk billing GP clinics in WA has doubled since the federal government introduced the Bulk Billing Incentive Program.
Domestic violence prevention: A closer look at medical intervention
Rates of domestic violence are increasing at an alarming rate across the country, with healthcare practitioners playing an important role in prevention and referral to support services.
Medical college involvement 'critical to the future of SIMG pathway'
Reducing unnecessary regulatory burdens for qualified specialist international medical graduates is important, but proposed revisions to the pathways into Australia raise some concerns, the AMA has said.
Cyber security reminder as telehealth company hit by data breach
Healthcare organisations are urged to make sure their cyber security processes are up to date as the use of AI and telehealth increases.
New prostate cancer screening guidelines are here
New guidelines for prostate cancer testing are here, with men under 50 and over 70 now able to have testing through their GP.
Doctors a 'target' in discussions about healthcare costs
The AMA has said doctors have become handy targets in discussions about healthcare costs as it rejected proposals to strengthen rules around informed financial consent.
